The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA *
S. Nymo,T. Ueland,T. Ueland,E. T. Askevold,T. Flo,J. Kjekshus,Johannes Hulthe,Johannes Hulthe,J. Wikstrand,J. McMurray,D. V. Veldhuisen,Lars Gullestad,Lars Gullestad,P. Aukrust,P. Aukrust
DOI: https://doi.org/10.1111/j.1365-2796.2011.02503.x
2011-11-22
Journal of Internal Medicine
Abstract:Abstract. Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A (Oslo University Hospital Rikshospitalet; University of Oslo; Oslo; Norwegian University of Technology and Science, Trondheim, Norway; Gothenburg University, Gothenburg; AstraZeneca, Mölndal, Sweden; University of Glasgow, UK; and University Medical Center Groningen, University of Groningen, The Netherlands). The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA. J Intern Med 2012; 271: 436–443.